Literature DB >> 9023523

The long-term use of benzodiazepines: patients' views, accounts and experiences.

G Barter1, M Cormack.   

Abstract

BACKGROUND: Although a decrease in new prescribing has occurred for anxiolytic benzodiazepines, concerns have been raised that a 'core' of long-term users has been left behind. Typically, elderly people represent this 'core', using the benzodiazepines as hypnotics.
OBJECTIVE: The present study focuses on the reasons why hypnotic benzodiazepines are used for protracted lengths of time. By examining patient experiences and cognitions, a deeper understanding may be gained of why patients continue to use benzodiazepines.
METHODS: Elderly, long-term users of benzodiazepine hypnotics were interviewed using a semi-structured interview procedure. A comparison group of non-users of the drugs were given a brief interview to collect comparative data. Interview data were analysed from transcripts using qualitative methodology; statistical comparisons between the groups were made using non-parametric statistics.
RESULTS: The long-term users had significantly fewer hours of sleep per night than the non-users. There was some evidence of tolerance and a suggestion that symptoms of withdrawal were maintaining continual use. None of the long-term users had clean knowledge of what their doctors thought of their use of benzodiazepines.
CONCLUSIONS: The data suggest that the power of the doctor may not be utilized to its full potential in the prevention of long-term use, that at least 50% of elderly benzodiazepine users would like to discontinue use, and that patients need information and advice on how to discontinue these drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9023523     DOI: 10.1093/fampra/13.6.491

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  16 in total

1.  Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians' attitudes toward benzodiazepine prescribing.

Authors:  Sibyl Anthierens; Inge Pasteels; Hilde Habraken; Pascale Steinberg; Tom Declercq; Thierry Christiaens
Journal:  Can Fam Physician       Date:  2010-11       Impact factor: 3.275

2.  Experiences of sleep and benzodiazepine use among older women.

Authors:  Sarah L Canham; Robert L Rubinstein
Journal:  J Women Aging       Date:  2015-01-12

3.  Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire.

Authors:  Emily Reeve; Sepehr Shakib; Ivanka Hendrix; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2012-10-09

Review 4.  Sleep disorders in the elderly.

Authors:  R Asplund
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

5.  Primary care providers' perspectives on psychoactive medication disorders in older adults.

Authors:  Monica Payne; Megan Gething; Alison A Moore; M Carrington Reid
Journal:  Am J Geriatr Pharmacother       Date:  2011-05-08

6.  First benzodiazepine prescriptions: qualitative study of patients' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Myriam Deveugele; Jan De Maeseneer; Thierry Christiaens
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

Review 7.  Qualitative studies of insomnia: Current state of knowledge in the field.

Authors:  Taís Araújo; Denise C Jarrin; Yvan Leanza; Annie Vallières; Charles M Morin
Journal:  Sleep Med Rev       Date:  2016-01-14       Impact factor: 11.609

8.  Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines.

Authors:  Joan M Cook; Tatyana Biyanova; Richard Thompson; James C Coyne
Journal:  Gen Hosp Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.238

9.  Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines.

Authors:  Julie D Morgan; David J Wright; Henry Chrystyn
Journal:  Pharm World Sci       Date:  2002-12

Review 10.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.